Bluejay Diagnostics, Inc. Payments of Stock Issuance Costs
Bluejay Diagnostics, Inc. (BJDX) reported Payments of Stock Issuance Costs of $1.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-06
- Bluejay Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $787.75K.
- Bluejay Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
- Bluejay Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00.
- Bluejay Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Bluejay Diagnostics, Inc. payments of stock issuance costs for fiscal 2025 was $1.25M, a 32.10% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. payments of stock issuance costs for fiscal 2024 was $1.84M, a 346.01% increase from fiscal 2023.
- Bluejay Diagnostics, Inc. payments of stock issuance costs for fiscal 2023 was $413.54K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $787.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $787.75K derived: sum of 2 quarters · filed 2026-03-06 | $1.25M 10-K · filed 2026-03-06 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $464.67K 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $464.67K 10-Q · filed 2025-08-07 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-06 | $1.13M derived: sum of 3 quarters · filed 2026-03-06 | $1.84M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.13M derived: sum of 2 quarters · filed 2025-11-07 | $1.84M 10-Q · filed 2025-11-07 | $1.84M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.84M 10-Q · filed 2025-08-07 | $1.84M derived: sum of 3 quarters · filed 2025-08-07 | $2.26M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $711.03K 10-Q · filed 2025-05-13 | $445.95K 10-Q · filed 2024-05-15 | $711.03K derived: sum of 2 quarters · filed 2025-05-13 | $1.12M derived: sum of 3 quarters · filed 2025-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $413.54K derived: sum of 2 quarters · filed 2025-03-31 | $413.54K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $413.54K 10-Q · filed 2023-11-09 | $413.54K 10-Q · filed 2024-11-07 | |||
| 2021-09-30 | $393.45K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |